Ascension Ventures (AV), a strategic healthcare venture firm representing thirteen of the nation’s leading non-for-profit health systems, announced today the completion of an investment in Strive Health (Strive), a new company launched to fundamentally change the lives of kidney disease patients through early engagement, comprehensive coordinated care, and expanded treatment options.
“Strive’s integrated approach to kidney care will be transformative for millions of patients with kidney disease, and we are excited to partner with AV in changing kidney care in America,” said Chris Riopelle, CEO of Strive Health. “We see health systems as a critical partner in delivering best in class kidney care. AV and its leading health system limited partners will be of tremendous strategic value to Strive as we continue to grow and scale the company.”